ES2087623T3 - Derivados de bencimidazol como agente antimicrobiano contra campylobacter pylon. - Google Patents

Derivados de bencimidazol como agente antimicrobiano contra campylobacter pylon.

Info

Publication number
ES2087623T3
ES2087623T3 ES93113149T ES93113149T ES2087623T3 ES 2087623 T3 ES2087623 T3 ES 2087623T3 ES 93113149 T ES93113149 T ES 93113149T ES 93113149 T ES93113149 T ES 93113149T ES 2087623 T3 ES2087623 T3 ES 2087623T3
Authority
ES
Spain
Prior art keywords
bencimidazole
pylon
derivatives
antimicrobial agent
agent against
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93113149T
Other languages
English (en)
Inventor
Masaru Sato
Shigeru Souda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eisai Co Ltd
Original Assignee
Eisai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd
Application granted granted Critical
Publication of ES2087623T3 publication Critical patent/ES2087623T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Abstract

LOS COMPUESTOS QUE TIENEN LA SIGUIENTE FORMULA (I) EN LA QUE N ES 0 O 1; O SALES FARMACEUTICAMENTE ACEPTABLES DE ESTOS PUEDEN SER USADAS PARA LA PREPARACION DE UN MEDICAMENTO PARA PREVENIR ,MEJORAR Y TRATAR UNA ENFERMEDAD CAUSADA POR LA BACTERIA CAMPYLOBACTER PYLORI, EN PARTICULAR ULCERA PEPTICA O GASTRITIS O ENFERMEDADES INFECCIOSAS, Y PARA ERRADICAR LA BACTERIA CAMPYLOBACTER PYLORI DE LA MEMBRANA DE LAS MUCOSAS DE UN PACIENTE Y PREVENIR LA RECURRENCIA DE UNA ENFERMEDAD CAUSADA POR CAMPYLOBACTER PYLORI.
ES93113149T 1992-08-21 1993-08-17 Derivados de bencimidazol como agente antimicrobiano contra campylobacter pylon. Expired - Lifetime ES2087623T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP24404292 1992-08-21

Publications (1)

Publication Number Publication Date
ES2087623T3 true ES2087623T3 (es) 1996-07-16

Family

ID=17112856

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93113149T Expired - Lifetime ES2087623T3 (es) 1992-08-21 1993-08-17 Derivados de bencimidazol como agente antimicrobiano contra campylobacter pylon.

Country Status (10)

Country Link
US (1) US5916904A (es)
EP (1) EP0585722B1 (es)
AT (1) ATE137969T1 (es)
CA (1) CA2104531C (es)
DE (1) DE69302646T2 (es)
DK (1) DK0585722T3 (es)
ES (1) ES2087623T3 (es)
FI (1) FI933681A (es)
GR (1) GR3019917T3 (es)
NO (1) NO307689B1 (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5504082A (en) * 1992-06-01 1996-04-02 Yoshitomi Pharmaceutical Industries, Ltd. Pyridine compound and pharmaceutical compostions
US6673827B1 (en) 1999-06-29 2004-01-06 The Uab Research Foundation Methods of treating fungal infections with inhibitors of NAD synthetase enzyme
US6861448B2 (en) 1998-01-14 2005-03-01 Virtual Drug Development, Inc. NAD synthetase inhibitors and uses thereof
WO1999036422A1 (en) * 1998-01-14 1999-07-22 The Uab Research Foundation Methods of synthesizing and screening inhibitors of bacterial nad synthetase enzyme, compounds thereof, and methods of treating bacterial and microbial infections with inhibitors of bacterial nad synthetase enzyme
CA2341506A1 (en) * 1998-08-25 2000-03-02 The Uab Research Foundation Inhibitors of bacterial nad synthetase
US6174902B1 (en) 1999-04-28 2001-01-16 Sepracor Inc. R-rabeprazole compositions and methods
US6262085B1 (en) 1999-08-26 2001-07-17 Robert R. Whittle Alkoxy substituted Benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
US6369087B1 (en) 1999-08-26 2002-04-09 Robert R. Whittle Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
US6268385B1 (en) 1999-08-26 2001-07-31 Robert R. Whittle Dry blend pharmaceutical formulations
US6780880B1 (en) 1999-08-26 2004-08-24 Robert R. Whittle FT-Raman spectroscopic measurement
US6312712B1 (en) 1999-08-26 2001-11-06 Robert R. Whittle Method of improving bioavailability
US6262086B1 (en) 1999-08-26 2001-07-17 Robert R. Whittle Pharmaceutical unit dosage form
US6312723B1 (en) 1999-08-26 2001-11-06 Robert R. Whittle Pharmaceutical unit dosage form
US6326384B1 (en) 1999-08-26 2001-12-04 Robert R. Whittle Dry blend pharmaceutical unit dosage form
US6316020B1 (en) * 1999-08-26 2001-11-13 Robert R. Whittle Pharmaceutical formulations
EP1611901B1 (en) * 2003-03-13 2013-07-10 Eisai R&D Management Co., Ltd. Preventive or remedy for teeth grinding

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI90544C (fi) * 1986-11-13 1994-02-25 Eisai Co Ltd Menetelmä lääkeaineina käyttökelpoisten 2-pyridin-2-yyli-metyylitio- ja sulfinyyli-1H-bensimidatsolijohdannaisten valmistamiseksi
ATE114114T1 (de) * 1989-02-10 1994-12-15 Takeda Chemical Industries Ltd Verwendung von benzimidazol-derivaten als antibakterielle mittel.
JPH0348680A (ja) * 1989-07-18 1991-03-01 Yoshitomi Pharmaceut Ind Ltd 抗菌剤

Also Published As

Publication number Publication date
FI933681A0 (fi) 1993-08-20
EP0585722B1 (en) 1996-05-15
FI933681A (fi) 1994-02-22
GR3019917T3 (en) 1996-08-31
DE69302646D1 (de) 1996-06-20
CA2104531C (en) 1999-01-05
DK0585722T3 (da) 1996-08-05
NO932947L (no) 1994-02-22
US5916904A (en) 1999-06-29
CA2104531A1 (en) 1994-02-22
EP0585722A1 (en) 1994-03-09
ATE137969T1 (de) 1996-06-15
NO932947D0 (no) 1993-08-19
NO307689B1 (no) 2000-05-15
DE69302646T2 (de) 1996-10-31

Similar Documents

Publication Publication Date Title
ES2087623T3 (es) Derivados de bencimidazol como agente antimicrobiano contra campylobacter pylon.
ATE133861T1 (de) Antihypertensive zubereitungen und deren verwendung
GEP20002298B (en) Benzimidazole Derivatives, Method of Their Production, Pharmaceutical Composition Containing the Same and Method for Its Treatment
DE69529670D1 (de) Oxazolidinon derivate und diese enthaltende pharmazeutische zusammensetzungen
ATE188119T1 (de) Heilmittel für wunden und hämorrhoiden
EP0444196A4 (en) Agent for treatment and prophylaxis of ischemic disease of heart or brain
AU3453493A (en) Pharmaceutical preparation based on rhamnolipid against dermatological diseases, e.g. papilloma virus infections
AR018335A1 (es) Compuesto carbapenico, agente antibacteriano que lo comprende y compuesto carbapenico util como intermediario para la obtencion del primero
KR890008136A (ko) 항균성 9-데옥소-9a-알릴 및 프로파길-9a-아자-9a-호모에리트로 마이신 A 유도체
KR890003378A (ko) 혐기성균에 대해 항균작용을 갖는 나프티리딘 화합물
KR880007070A (ko) 백내장 치료용 약학 조성물
ES2104223T3 (es) 2-((2-(n-isobutil-n-metil)amino)-bencilsulfinil)bencimidazol como agente antimicrobiano contra helicobacter pylori.
FI932654A (fi) Hydroxamsyraderivat, som hindrar lipoxigenas
DK0913151T3 (da) Anti-helicobacter Pylori-præparater indeholdende 1-methylcarbapenemderivater som den aktive bestanddel
KR890003755A (ko) 7- (2- 메틸- 4- 아미노피롤리디닐)나프티리딘 및 퀴놀린 화합물
ATE147755T1 (de) Dipeptidderivate und diese als aktive bestandteile enthaltendes prophylaktisches oder therapeutisches mittel gegen knochenkrankheiten
AU7237698A (en) Medicinal compositions against helicobacter pylori
KR900016130A (ko) 2-피리딜메틸티오 유도체 및 궤양 치료제
AU2001260695A1 (en) Malto-oligosaccharide derivatives and use thereof
BR9814815A (pt) Agente para o tratamento de leishmaniose com um derivado de glicopiranose como ingrediente eficaz
KR890001555A (ko) 요산 배설용 조성물
HK34095A (en) Use of 2-oxo-imidazolidine derivatives in the treatment of kidney diseases
FI941850A0 (fi) Uusi yhdiste, joka on leustroduksiini H, sen valmistus ja terapeuttinen käyttö
KR880012228A (ko) 천식 치료제

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 0585722

Country of ref document: ES